Czech J. Food Sci., 2006, 24(3):119-126 | DOI: 10.17221/3306-CJFS

Antimutagenic effect of genistein

Zdeňka Polívková1, Martina Langová1, Petr ©merák1, Jiřina Bártová2, Ivo Bárta1
1 Division of General Biology and Genetics, Center of Biomedical Sciences and
2 Division of General Hygiene, Center of Preventive Medicine, 3 rd Faculty of Medicine, Charles University, Prague, Czech Republic

A great variety of health benefits including the protection against breast and prostate cancers has been attributed to the soya consumption, because of the presence of soy beans isoflavones, genistein, and others. We investigated the antigenotoxic effect of genistein on the genotoxicity of three mutagens and carcinogens - aflatoxine B1 (AFB1), 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), and N-nitroso-N-methylurea (MNU), using the Ames bacterial mutagenicity test and the micronucleus test. In the Ames test on Salmonella typhimurium, a significant antimutagenic effect was determined against the indirect mutagen AFB1 in two strains, TA98 and TA100. However, the effect on the IQ indirect mutagenicity was more pronounced in the test with TA98 than with TA100. The mutagenicity of the direct mutagen MNU was suppressed by genistein only at its highest concentration used (300 µg/plate). The protective effect of genistein against all three mutagens was proved in the micronucleus test as the treatment of mice with the combinations of genistein and mutagens resulted in a significant reduction of the number of micronuclei in comparison with the number of micronuclei induced by the individual mutagens alone.

Keywords: chemoprevention; aflatoxin B1; 2-amino-3-methylimidazo [4,5-f]quinoline; N-nitroso-N-methylurea; Ames test; micronucleus test

Published: June 30, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polívková Z, Langová M, ©merák P, Bártová J, Bárta I. Antimutagenic effect of genistein. Czech J. Food Sci. 2006;24(3):119-126. doi: 10.17221/3306-CJFS.
Download citation

References

  1. ADLERCREUTZ H., HONJO H., HIGASHI A., FOTSIS T., HAMALAINEN E., HASEGAWA T., OKADA H. (1991): Urinary excretion of lignins and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional diet. American Journal of Clinical Nutrition, 54: 1093-1100. Go to original source... Go to PubMed...
  2. AMES B.N. (1971): The detection of chemical mutagens with enteric bacteria. In: HOLLAENDER A. (ed.): Chemical Mutagens. Principle and Methods for their Detection 1. Plenum, New York: 267-282. Go to original source...
  3. AMES B.N., MCCANN J., YAMASAKI E. (1975): Methods for detection of carcinogens and mutagens with Salmonella/mammalian-microsome mutagenicity test. Mutation Research, 31: 347-364. Go to original source... Go to PubMed...
  4. BOOS G., STOPPER H. (2000): Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicology Letters, 116: 7-16. Go to original source... Go to PubMed...
  5. BOUKER K.B., HILAKIVI-CLARKE L. (2000): Genistein: Does it prevent or promote breast cancer? Environmental Health Perspectives, 108: 701-708. Go to original source... Go to PubMed...
  6. ČERNÁ M., DOBIÁ© L., HÁJEK V. (1989): Amesova metoda. V. Metody biologického monitorování genotoxických účinků faktorů prostředí - Standardní metodika. Acta Hygienica, Epidemiologica et Microbiologica, 20: 33-56.
  7. CHOI Y.H., LEE W.H., PARK K., ZHANG L. (1998a): P53independent induction of p21 WAF1/CIP1, reduction of cyclin B1 and G2/M arrest by isoflavone genistein in human prostate carcinoma cells. Japanese Journal of Cancer Research, 91: 164-173. Go to original source... Go to PubMed...
  8. CHOI Y.H., ZHANG L., LEE W.H., PARK K. (1998b): Genistein-induced G2/M arrest is associated with the inhbition of cyclin B1 and the induction of p21 in human breast carcinoma cells. International Journal of Oncology, 13: 391-396. Go to original source... Go to PubMed...
  9. CORNWELL T., COHICK W., RASKIN I. (2004): Dietary phytoestrogens and health. Phytochemistry, 65: 995-1016. Go to original source... Go to PubMed...
  10. DINGLEY K.H., UBICK E.A., CHIARAPPA-ZUCCA M.L., NOWELL S., ABEL S., EBELER S.E., MITCHELL A.E., BURNS S.A., STEINBERG F.M., CLIFFORD A.J. (2003): Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutrition and Cancer, 46: 212-221. Go to original source... Go to PubMed...
  11. DIXON R.A., FERREIRA D. (2002): Molecules of interest: genistein. Phytochemistry, 60: 205-211. Go to original source... Go to PubMed...
  12. GOODMAN M.T., WILKENS L.R., HANKIN J.H., HYU L.C., WU A.H., KOLONEL L.N. (1997): Association of soy and fiber consumption with the risk of endometrial cancer. American Journal of Epidemiology, 146: 294-306. Go to original source... Go to PubMed...
  13. HERBERT J., HURLEY T., OLENDZKI B., TEAS J., YUNSHENG M. et al. (1998): Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. Journal of National Cancer Institute, 90: 1637-1647. Go to original source... Go to PubMed...
  14. KUMI-KIAKA J., SANDERSON N.A., HALL A. (2000): The mediating role of caspase-3 protease in the intracellular mechnism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biological Cell, 92: 595-604. Go to original source... Go to PubMed...
  15. LAMARTINIERE C.A., COTRONEO M.S., FRITZ W.A., WANG J., MENTOR-MARCEL R., ELGAVISH A. (2002): Genistein chemoprevention: Timing and mechanisms of action in murine mammary and prostate. Journal of Nutrition (Suppl.), 132: 552S-558S. Go to original source... Go to PubMed...
  16. LEE H.P., GOURLEY L., DUFFY S.W., ESTEVE J., LEE J., DAY N.E. (1991): Dietary effects on breast cancer risk in Singapore. Lancet, 336: 1197-1200. Go to original source... Go to PubMed...
  17. MARON D.M., AMES B.N. (1983): Revised methods for the Salmonella mutagenicity tests. Mutation Research, 113: 173-215. Go to original source... Go to PubMed...
  18. MESSINA M.J., LOPRINZI CH.L. (2001): Soy for breast cancer survivors: A critical review of the literature. Journal of Nutrition (Suppl.), 132: 3095S-3108S. Go to original source... Go to PubMed...
  19. MISRA R.R., HURSTING S.D., PERKINS S.N., SATHYAMOORTHY N., MIRSALIS J.C., RICCIO E.S., CROWELL J.A. (2002): Genotoxicity and carcinogenicity studies of soy isoflavones. International Journal of Toxicology, 21: 277-285. Go to original source... Go to PubMed...
  20. MIYAZAWA M., SAKANO K., NAKAMURA S., KOSAKA H. (1999): Antimutagenic activity of isoflavones from soybean seeds (Glycine max merrill). Journal of Agricultural and Food Chemistry, 47:13456-1349. Go to original source... Go to PubMed...
  21. PARK O.J., SURH Y.J. (2004): Chemoprotective potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicology Letters, 150: 43-56. Go to original source... Go to PubMed...
  22. POLKOWSKI K., MAZUREK A.P. (2000): Biological properties of genistein. Review of an in vitro and in vivo data. Acta Poloniae Pharmaceutica - Drug Research, 57: 135-155.
  23. ROSENBERG ZAND R.S., JENKINS D.J.A., DIAMANDIS E.P. (2002): Flavonoids and steroid hormone-dependent cancers. Journal of Chromatography B, 777: 219-232. Go to original source... Go to PubMed...
  24. SARKAR F.H., LI Y. (2002): Mechanisms of cancer chemoprevention by soy isoflavone genistein.Cancer and Metastasis Reviews, 21: 265-280. Go to original source... Go to PubMed...
  25. SARKAR F.H., LI Y. (2004): Cell signaling pathways altered by natural chemopreventive agents. Mutation Research, 555: 53-64. Go to original source... Go to PubMed...
  26. SCHMID W. (1975): The micronucleus test. Mutation Research, 31: 9-15. Go to original source... Go to PubMed...
  27. SNYDER R.D., GILLIES P.J. (2002): Evaluation of clastogenic, DNA intercalative and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environmental and Molecular Mutagenesis, 40: 266-276. Go to original source... Go to PubMed...
  28. STOPPER H., SCHMITT E., KOBRAS K. (2005): Genotoxicity of phytoestrogens. Mutation Research, 574: 139-155. Go to original source... Go to PubMed...
  29. TSUTSUI T., TAMURA Y., YAGI E., SOMEY A.H., HORI I., METZLER M., BARRET J.C. (2003): Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. International Journal of Cancer, 105: 312-320. Go to original source... Go to PubMed...
  30. WEISBURGER J.H., DOLAN L., PITTMAN B. (1998): Inhibition of PhIP mutagenicity by caffeine, lycopene, daizien and genistein. Mutatation Research, 416: 125-128. Go to original source... Go to PubMed...
  31. ZHENG W., DAI Q., CUSTER L., SHU X.O., WEN W.Q., JIN F., FRANKE A.A. (1999): Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiology Biomarkers & Prevention, 8: 35-40.
  32. ZIEGLER R.G., HOOVER R.N., PIKE M.C., HILDESHEIM A., NOMURA A.M., WEST D.W., WU-WILLIAMS A.H., KOLONEL L.N., HORN-ROSS P.L., ROSENTHA J.F. et al. (1993): Migration patterns and breast cancer risk in Asian-American women. Journal of National Cancer Institute, 85: 1819-1827. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.